Tirzepatide, a groundbreaking drug, represents a significant step forward in the approach of type 2 diabetes and, more recently, obesity. This dual agonist acts upon two crucial receptors: glucagon-like peptide-1 and https://roryuknh644551.mpeblog.com/72910198/exploring-tirzepatide-a-comprehensive-overview